Journals
Publish with us
Publishing partnerships
About us
Blog
Case Reports in Nephrology
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Case Reports in Nephrology
/
2017
/
Article
/
Tab 1
/
Case Report
Cetuximab-Associated Crescentic Diffuse Proliferative Glomerulonephritis
Table 1
Patient’s sodium (mmol/l), potassium (mmol/l), BUN (mg/dl), creatinine (mg/dl), serum albumin (gm/dl), proteinuria (mg/dl), and hematuria (per hpf) during 7 cycles of cetuximab treatment and 3 weeks later after completing 7th cycle of treatment.
1st cycle
2nd cycle
3rd cycle
4th
cycle
5th
cycle
6th
cycle
7th
cycle
3 weeks later
Sodium
130
133
133
136
133
130
131
134
Potassium
4.5
4.9
4.4
4.6
4.4
4.5
4.3
4.1
BUN
20
24
25
30
19
19
18
100
Creatinine
0.8
0.7
0.7
0.7
0.7
0.8
0.8
6.6
Serum albumin
3.2
3.7
3.5
3.3
3.0
3.1
2.4
1.5
Proteinuria
30
n/a
n/a
n/a
n/a
n/a
n/a
>500
Hematuria
1
n/a
n/a
n/a
n/a
n/a
n/a
81